Sharp Eye Medicare Private Limited
About Sharp Eye Medicare Private Limited
Data last updated: 12 March 2026
Sharp Eye Medicare Private Limited is a private limited company based in North, Delhi, India. It specialises in office and school supplies, a part of the broader education sector. Incorporated on 02 July 2010, the company has been in operation for over 16 years.
Registered with ROC Delhi under CIN U74110DL2010PTC205120.
Capital: an authorised share capital of ₹55 Lakh and a paid-up capital of ₹1 Lakh. Formerly known as Sharp Eye Communications Private Limited and Softline Medicare Private Limited. It is led by directors Jyoti Dikshit and Pooja Aggarwal.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No D – 7 – B Kh.No. 31/18/2 1St Floor, Opp. Street No 2 Hardev Nagar, North, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹99,840, a decline of 96% compared to the previous year.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email*****@*****.com
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressPlot No D – 7 – B Kh.No. 31/18/2 1St Floor, Opp. Street No 2 Hardev Nagar, North, Delhi, India – 110084
-
IndustryEducation, Office & School Supplies
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited has undergone 2 name changes throughout its history. The company was previously known as Sharp Eye Communications Private Limited, and Softline Medicare Private Limited. The current legal name is Sharp Eye Medicare Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Sharp Eye Medicare Private Limited | Current |
| Sharp Eye Communications Private Limited | Previous |
| Softline Medicare Private Limited | Previous |
CIN History of Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74110DL2010PTC205120, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110DL2010PTC205120 | Current |
| U74140DL2010PTC205120 | Previous |
| U92140DL2010PTC205120 | Previous |
| U85100DL2010PTC205120 | Previous |
Auditor Details of Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited is audited by B. A. S. & CO. LLP for the financial year 2019. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B. A. S. & CO. LLP | blur-value | blur-value | blur-value |
Board of Directors of Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited is currently managed by 2 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Jyoti Dikshit
Also directs:
Mp Infracon Private Limited, Ipk Exports Private Limited, Pomez Lifestyle Llp and 1 more
|
Director | 22 Oct 2022 | 3 Years 8 Months | Current |
| Pooja Aggarwal | Director | 18 Mar 2021 | 5 Years 3 Months | Current |
Financials of Sharp Eye Medicare Private Limited FY 2025 filings available
Sharp Eye Medicare Private Limited reported revenue of ₹99,840 (down 96% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Sharp Eye Medicare Private Limited
As of FY 2019, Sharp Eye Medicare Private Limited's shareholding pattern shows 78.92% by promoters, 21.08% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sharp Eye Medicare Private Limited
View historical data on people associated with Sharp Eye Medicare Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Sharp Eye Medicare Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Sharp Eye Medicare Private Limited
GSTIN & GST Filing Data of Sharp Eye Medicare Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Sharp Eye Medicare Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Sharp Eye Medicare Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Sharp Eye Medicare Private Limited
MSME Payment Delays by Sharp Eye Medicare Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Sharp Eye Medicare Private Limited
Subsidiaries & Group Companies of Sharp Eye Medicare Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sharp Eye Medicare Private Limited with ownership details.
MCA Filings & Documents of Sharp Eye Medicare Private Limited
MCA Filings & Documents of Sharp Eye Medicare Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Sharp Eye Medicare Private Limited
Frequently Asked Questions about Sharp Eye Medicare Private Limited
Sharp Eye Medicare Private Limited is an active private limited company in the education sector based in North, Delhi, India. It was incorporated on 02 July 2010 (16+ years old) and is registered under CIN U74110DL2010PTC205120.
Sharp Eye Medicare Private Limited reported revenue of ₹99,840 for FY 2025 (down 96.00% YoY).
The current directors of Sharp Eye Medicare Private Limited are:
The primary industry of Sharp Eye Medicare Private Limited is education. The company specifically operates in office and school supplies. The company is currently active in this sector.
Sharp Eye Medicare Private Limited can be reached at the registered office: Plot No D – 7 – B Kh.No. 31182 1St Floor, Opp. Street No 2 Hardev Nagar, North, Delhi, India – 110084.
The authorised capital is ₹55 Lakh, and the paid-up capital is ₹1 Lakh.